Short Bowel Syndrome Market: Current Analysis and Forecast (2021-2027)

$3999$6999

Emphasis on Product (Glucagon-like Peptide-2 (GLP2), Growth Hormone, Glutamine, Others); Distribution Channel (Hospitals Pharmacies, Retail pharmacies, Online Sales); Region/Country

Detailed Analysis of COVID-19 Impact on the Short Bowel Syndrome Market

Pages:

164

Table:

32

Figure:

76

Report ID:

UMHE211035

Geography:

Clear
  Get a Free Sample
SKU: UMHE211035 Categories: , Tag:
Report Description
Table of content
Research Methodology

Report Description

short bowel syndrome market
short bowel syndrome market

REQUEST FREE SAMPLE PDF

The short bowel syndrome market is expected to register a CAGR of around 27% over the period of 2021-2027. Short bowel syndrome (SBS) is a metabolic disorder caused by dysfunction or elimination of the small intestine due to surgery for gastrointestinal disorders. The side effects of this syndrome include malabsorption, diarrhea, steatorrhea, water and electrolyte imbalances, and malnutrition. Initial treatment for short bowel syndrome includes maintaining good nutrition, maximizing the absorption area of ​​the remaining intestine, and avoiding complications. The growing number of cases of short bowel syndrome is mainly due to an increase in diseases related to the intestine, genetic inheritance of SBS, etc. For instance, according to the National Institute of Diabetes and Digestive & Kidney Diseases, every year, short bowel syndrome affects nearly 3 out of every million people. Furthermore, the short bowel syndrome market is also anticipated to grow on account of the growing healthcare expenditure, rapid improvements in the field of healthcare have increased awareness regarding this disease, and state government with nonprofit organizations provide special incentives to market players as it promotes research & development related to short bowel syndrome.

Takeda Pharmaceutical Company Limited, Merck KGaA, Zealand Pharma A/S, OxThera, VectivBio AG, 9 Meters Biopharma Inc., Nutrinia Ltd., Hanmi Pharm.Co., Ltd., Pharmascience, Inc., and Nestle are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

REQUEST FOR CUSTOMIZATION

Insights Presented in the Report

“Amongst Product, the Glucagon-like peptide-2 (GLP2) category accounted for the majority share in the market in 2020”

Based on product, the market is classified into glucagon-like peptide- 2 (GLP2), growth hormone, glutamine, and others. Amongst products, the GLP2 category accounted for a significant share of the market. The only GLP-2 analog available on the market for the treatment of short bowel syndrome is Gattex and Revestive. the increase in prescriptions for Gattex therapy contributes to the growth of the market.

“Among Distribution Channel, the Hospital Pharmacies is expected to witness highest CAGR during the forecast period”

Based on distribution channels, the market is categorized into hospital pharmacies, retail pharmacies, and online sales. Among these, the hospital pharmacies are expected to witness a considerable CAGR during the forecast period due to an increase in patients in hospital settings and rising implementation of therapy. Moreover, patient preference for affordable and more expensive parenteral nutrition along with prescription drugs contributes to a large share of this segment.

“North America to witness significant growth during the forecast period”

For a better understanding of the market dynamics of the short bowel syndrome market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the short bowel syndrome in 2020 owing to due to the revenue generated by Gattex, the only glucagon-like peptide-2 (GLP-2) analog approved that improves intestinal absorption in patients with SBS in the U.S.

SPEAK TO ANALYST

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
  • The report presents a quick review of overall industry performance at one glance.
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
  • The study comprehensively covers the market across different segments.
  • Deep dive regional level analysis of the industry.


Customization Options:

Global short bowel syndrome market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1.Market Definitions 
1.2.Limitation 
1.3.Stakeholders 
1.4.Currency used in Report
2.1.Research Process of the Short Bowel Syndrome Market
2.2.Research Methodology of the Short Bowel Syndrome Market
2.3.Forecasting Method  
2.4.Respondent Profile  
2.5.Main Objective of the Short Bowel Syndrome Market Study
3MARKET SYNOPSIS 
4EXECUTIVE SUMMARY
5GLOBAL SHORT BOWEL SYNDROME MARKET COVID-19 IMPACT
6GLOBAL SHORT BOWEL SYNDROME MARKET REVENUE, 2019-2027F
7.1.Glucagon-like Peptide-2(GLP2)
7.2.Growth Hormone
7.3.Glutamine
7.4.Others 
8.1.Hospital Pharmacies
8.2.Retail Pharmacies
8.3.Online Sales
9.1.North America Short Bowel Syndrome Market 
 9.1.1.United States
 9.1.2.Canada
 9.1.3.Rest of North America
9.2.Europe Short Bowel Syndrome Market 
 9.2.1.Germany
 9.2.2.France
 9.2.3.United Kingdom
 9.2.4.Italy
 9.2.5.Spain
 9.2.6.Rest of Europe
9.3.Asia Pacific Short Bowel Syndrome Market
 9.3.1.China
 9.3.2.Japan
 9.3.3.India
 9.3.4.Australia
 9.3.5.Rest of Asia Pacific
9.4.Rest of World Short Bowel Syndrome Market 
10.1.Market Drivers
10.2.Market Challenges
10.3.Impact Analysis
11SHORT BOWEL SYNDROME MARKET OPPORTUNITIES
12SHORT BOWEL SYNDROME MARKET TRENDS
13LEGAL & REGULATORY FRAMEWORK
14.1.Demand Side Analysis
14.2.Supply Side Analysis
15VALUE CHAIN ANALYSIS
16.1.Competitive Landscape
 16.1.1.Porter’s Five Forces Analysis
17.1.Takeda Pharmaceutical Company Limited
17.2.Merck KGaA
17.3.Zealand Pharma A/S
17.4.OxThera 
17.5.VectivBio AG
17.6.9 Meters Biopharma, Inc.
17.7.Nutrinia Ltd.
17.8.Hanmi Pharm.Co., Ltd.
17.9.Pharmascience, Inc. 
17.10.Nestle   
18DISCLAIMER

Research Methodology

Research Methodology for the Global Short Bowel Syndrome Market Analysis (2021-2027)

Analyzing the historical market, estimation of the current market, and forecasting the future market of the global short bowel syndrome market were the three major steps undertaken to create and analyze the adoption of short bowel syndrome in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global short bowel syndrome market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:

Seek More Details About Research Methodology

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the short bowel syndrome market through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the short bowel syndrome market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report as product and distribution types. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the short bowel syndrome market. Further, we conducted factor analysis using dependent and independent variables such as various products and distribution types of short bowel syndrome. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, merger and acquisition, business expansion, and product launches in the Short bowel syndrome market sector across the globe.

REQUEST FOR CUSTOMIZATION

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global short bowel syndrome market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of revenue (USD) and the adoption rate of short bowel syndrome market across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the global short bowel syndrome market in terms of solutions offered. Also, the growth strategies adopted by these players to compete in the fast-growing market


Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

short bowel syndrome market
short bowel syndrome market

SPEAK TO ANALYST

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the global short bowel syndrome market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product and distribution type in the global short bowel syndrome market.

The main objective of the Global Short Bowel Syndrome Market Study

The current & future market trends of the global short bowel syndrome market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the short bowel syndrome market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of product and distribution channel.
  • Define and analysis of the regulatory framework for the short bowel syndrome market industry.
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
  • Analyze the current and forecast market size of the short bowel syndrome market for the major region.
  • Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the world.
  • Company profiles of the short bowel syndrome market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?